Chevy Chase Trust’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41M Sell
1,437,416
-66,659
-4% -$1.45M 0.11% 155
2026
Q1
$26.1M Buy
1,504,075
+422,733
+39% +$8M 0.08% 224
2025
Q4
$20.4M Buy
1,081,342
+337,591
+45% +$5.66M 0.06% 261
2025
Q3
$10.8M Buy
743,751
+231,202
+45% +$3.3M 0.03% 393
2025
Q2
$10M Sell
512,549
-22,792
-4% -$405K 0.03% 402
2025
Q1
$9.5M Buy
+535,341
New +$11.5M 0.03% 406

Other funds holding CDNA

Chevy Chase Trust's CDNA Position: Q2 2026 in Review

Chevy Chase Trust reduced its CareDx (CDNA) stake by 4.4% in Q2 2026, selling an estimated $1.45M and leaving 1,437,416 shares worth $41M. The position accounts for 0.11% of the portfolio, ranked #155.

Chevy Chase Trust first reported a position in CDNA in Q1 2025 and has held it in 6 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Chevy Chase Trust held 1,437,416 shares of CareDx worth $41M as of Q2 2026.
  • Chevy Chase Trust sold 66,659 CareDx shares in Q2 2026, an estimated $1.45M.
  • CareDx made up 0.11% of Chevy Chase Trust's portfolio in Q2 2026, its #155 holding.
  • Chevy Chase Trust first reported a position in CareDx in Q1 2025 and has held it in 6 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Chevy Chase Trust's 13F filing for Q2 2026, filed 14 Aug 2026.